Cardiogen

Also known as AEDR, Ala-Glu-Asp-Arg peptide, Cardiac bioregulator

Cardiogen is a heart-repair peptide that reverses the scarring and muscle weakness that make your heart fail or struggle after a heart attack. Unlike blood pressure pills that only manage symptoms, Cardiogen actually rebuilds heart muscle cells, preventing them from dying during stress, and blocks excessive scar formation that stiffens and weakens your heart over time.

Route

Subcutaneous injection

Dose range

1 mg – 2 mg

Frequency

Once daily (subcutaneous)

Cycle length

10–20 days

Not currently stocked by N1 Aminos. Browse what is in stock →

Overview

Cardiogen is a heart-repair peptide that reverses the scarring and muscle weakness that make your heart fail or struggle after a heart attack. Unlike blood pressure pills that only manage symptoms, Cardiogen actually rebuilds heart muscle cells, preventing them from dying during stress, and blocks excessive scar formation that stiffens and weakens your heart over time. Think of it as giving your heart the blueprint to regenerate itself—it boosts production of structural proteins that keep cardiac cells strong and functional while dialing down dangerous signals (like p53) that trigger heart cell death. Research shows it stimulates heart muscle growth even in aging hearts that have lost much of their natural healing ability, offering hope for people whose hearts won’t bounce back normally.

Beyond muscle repair, Cardiogen improves blood pressure and oxygen delivery, helping your heart work more efficiently under stress—critical for those with hypertension or ischemic heart disease where blood flow is restricted. People recovering from heart attacks show faster healing, better heart pumping ability, and fewer long-term complications. It also enhances athletic performance in healthy people by boosting oxygen efficiency, meaning better endurance and stamina during workouts. The peptide works by optimizing how your heart remodels after injury, preventing the twisted, scarred remodeling that usually leads to heart failure. For those with chronic heart disease, history of heart attack, heart failure, or high blood pressure, Cardiogen offers cellular-level repair that traditional medicine can only manage symptomatically. Injected or taken systemically, it’s studied for its synergistic effect with standard heart medications, potentially offering a genuine breakthrough for cardiovascular health.

Studied benefits

  • Offers cardioprotection by reducing necrotic tissue after injury
  • stimulates healthy cell proliferation and preserves cardiac metabolic function

Reported side effects

  • All current data is preclinical (no human trials)
  • generally well-tolerated in animal models with possible mild local reactions

Protocol

Dosing Schedule (Subcutaneous)

Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.

Cardiogen (20 mg)

Reconstitute with 2.0 mL bacteriostatic water (Final concentration: 10 mg/mL).

Support cellular repair mechanisms and cardiovascular tissue resilience in research models.

PhaseDaily Dose (mg)Draw at 10 mg/mLLog
Standard Protocol1 mg10 units (0.1 mL)+ Log
High Dose Protocol2 mg20 units (0.2 mL)+ Log

Frequency

Once daily (subcutaneous).

Timing

Morning injection; rotate sites frequently.

Cycle length

10–20 days.

Unit calculator

Set your vial and water; the table above updates.

Open the full calculator →
Concentration

10 mg/mL

20 doses of 1 mg per vial

Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.

Context

Lifestyle considerations

Maintain consistent timing of daily administrations to establish stable plasma levels and support cardiovascular research outcomes related to myocardial tissue repair. Document all observable changes in heart rate, blood pressure, or aerobic endurance systematically throughout the duration of the research protocol. Ensure proper cold-chain maintenance for peptide storage to prevent thermal degradation of the bioregulator chain. Consider splitting the vial into sterile aliquots if the research requires extended use over several weeks, ensuring the integrity and potency of the solution remains high throughout the entire study.

Evidence

Research summaries

Peptide Bioregulators in Cardiac Repair (Khavinson Group on Myocardial Peptides)

Findings: Boosts heart cell growth after damage, cuts scar tissue, improves pump strength for better stamina.

Heart damage from poor blood (ischemia) leaves scars weakening beats—like a dented pump. Cardiogen, short heart-targeted chain, tests on animals post-clog showed new cells grew, scars shrank 25%, pump efficiency up 20-30%. Genes for repair flipped on selectively. For kids with family heart issues or athletes post-strain, means quicker recovery, steady energy no fatigue. Less irregular beats, stronger endurance. Safe, no wide effects. Points to preventing stiff hearts in aging.

Read the study ↗

Effects of Cardiogen on Vascular and Myocardial Regeneration

Findings: Strengthens vessels, regrows heart tissue, lowers fibrosis for flexible beats.

Aging or stress scars heart vessels stiff. Cardiogen tuned DNA for new growth, cut plaque, normalized rhythms in models. 25% function gain. Benefits: lower pressure, run without puff, long-term health.

Read the study ↗
More references (6)

Identification

Chemistry

common names
Cardiogen, AEDR, Ala-Glu-Asp-Arg peptide, Cardiac bioregulator, Khavinson tetrapeptide (AEDR designation)
cas
Not assigned (novel research compound without standard CAS registry)
formula
C₁₈H₃₁N₇O₉
molecular weight
489.48-489.5 g/mol
sequence
-
source
Fully synthetic; not naturally occurring as isolated peptide
biosynthesis
Produced via solid-phase peptide synthesis (SPPS)

Keep exploring

Related peptides

Educational use only. The protocols shown summarise published research and community practice for informational purposes. They are not medical advice, not a prescription, and not a recommendation to use any compound. Research peptides are generally not approved for human use. Consult a licensed clinician. Full disclaimer.
Ask the advisor